Zoloft and Arterial occlusive disease - a phase IV clinical study of FDA data

Summary:

Arterial occlusive disease is reported as a side effect among people who take Zoloft (sertraline hydrochloride), especially for people who are female, 60+ old, also take Plavix, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Arterial occlusive disease when taking Zoloft. It is created by eHealthMe based on reports of 128,159 people who have side effects when taking Zoloft from the FDA, and is updated regularly.

What is Zoloft?

Zoloft has active ingredients of sertraline hydrochloride. It is often used in depression. eHealthMe is studying from 138,798 Zoloft users. Check the latest studies of Zoloft.

What is Arterial occlusive disease?

Arterial occlusive disease (slow process through which arteries throughout the body become progressively narrowed and eventually completely blocked) is found to be associated with 634 drugs and 888 conditions by eHealthMe. Check the latest studies of Arterial occlusive disease.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 25, 2026

128,159 people reported to have side effects when taking Zoloft.
Among them, 121 people (0.09%) have Arterial occlusive disease.

Could Zoloft cause Arterial occlusive disease?

Among these 121 people:

What is the gender of people who have Arterial occlusive disease when taking Zoloft? *

Click here to view

What is the age of people who have Arterial occlusive disease when taking Zoloft? *

Click here to view more results

* Approximation only. Some reports may have incomplete information.

Do you take Zoloft and have Arterial occlusive disease?

- Check whether Arterial occlusive disease is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Zoloft:

Zoloft (138,798 reports)

Arterial occlusive disease treatments and more:

Arterial occlusive disease (10,788 reports)

How severe was Arterial occlusive disease and when was it recovered:

Arterial occlusive disease in Zoloft

Expand to all the drugs that have ingredients of sertraline hydrochloride:

Arterial occlusive disease and drugs with ingredients of sertraline hydrochloride (167 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Zoloft:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Arterial occlusive disease:

Arterial occlusive disease (634 drugs)

Browse all the conditions that are associated with Arterial occlusive disease:

Arterial occlusive disease (888 conditions)

Related publications that referenced our studies

Izgi C, Erdem G, Mansuroglu D, Kurtoglu N, Kara M, Gunesdogdu F, "Severe hypokalemia probably associated with sertraline use", Annals of Pharmacotherapy, 2014 Jan .
Izgi C, Erdem G, Mansuroglu D, Kurtoglu N, Kara M, Gunesdogdu F, "Severe hypokalemia probably associated with sertraline use", Annals of Pharmacotherapy, 2014 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on sertraline hydrochloride (the active ingredients of Zoloft) and Zoloft (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.